Nice analyst call. Stock falls from high 50's to mid 40's and THAN they downgrade? GS is a joke. All they do is make money for themselves, NOT their clients. ABT has built one of the most solid franchises in pharma, and will prosper in the future. This is a great long term buying opportunity.
I do agree, the S & P is headed lower. Forward estimates are too high and based on government spending that is unsustainable.
I was hoping with this stupid downgrade that ABT stock price goes a bit lower than that, so that my business associates and I can load up. My group is planning to accumulate as many ABT shares as we possibly can. Abbott is considered one of the very best stock in the Pharmaceutical/Medical Devices companies. No matter what the moron at Goldman Sachs says.